A facemask configured to be used by multiple sized/shaped heads can include a primary, a secondary and a tertiary seal. In some embodiments, the primary seal is contact with the nose and cheek regions; the secondary seal is in contact with the chin region; and the tertiary seal is in contact with the cheek and chin regions. In some embodiments, the tertiary seal extends inwardly and outwardly when applied to the face. In some embodiments, the mask includes test scissors.

The invention relates to a drug and device system for the directed application of a substance into a hollow space, such as a hollow organ, or into a body cavity of a patient, i.e. a mammalian patient, in particular for use in the course of a therapeutic pneumoperitoneum. In particular, herein the present invention is for use in cancer/tumor treatment, including metastatic forms thereof, and is also directed to a kit and its use in a method of treatment, comprising the said drug and device system for the said directed application. Especially, the invention pertains to a sterile and closed prefilled drug containing (medical) device system for administering at least one pharmaceutically active substance (drug) by pressurized aerosol therapy (PAT) in a hollow organ, or preferably in a body cavity, of a patient, in particular a therapeutic pneumoperitoneum, comprising a flexible package, comprising at least one container comprising at least one pharmaceutically active substance in powder, lyophilisate, solution, liquid, gel or other form (suspension, emulsion), and being provided with breakable, an openable, or perforable cap; and a bag of liquid diluent), wherein the bag is optionally equipped with at least one drain tube provided with a closing device; and wherein the bag is equipped with a mixing tube, optionally equipped with an openable closure, and which optionally ends with a perforation device, which container is preferably a vial, syringe, single-use syringe, ampoule, phial, or bottle, comprising the said pharmaceutically active substance, and which container is provided with breakable, an openable, or perforable cap; and wherein said package is comprising at least one flexible airtight sterile casing, containing said container, preferably a vial, syringe, single-use syringe, ampoule, phial, or bottle, of the said pharmaceutically active substance, and said perforation device, said container being housed in the casing; and wherein the said container is manually maneuverable from the outside of the casing in order to be opened inside the closed casing, optionally is manually maneuverable from the outside of the casing up to a perforating position of said cap through the same perforation device; and whereupon after opening of the said container and of the said closure, and selectively mixing (i.e. dissolving, reconstituting) the at least one pharmaceutically active substance (drug) with the liquid diluent through the mixing tube, a solution of the at least one pharmaceutically active substance (drug) in the liquid diluent is provided for administering by pressurized aerosol therapy (PAT) in a hollow organ, or preferably in a body cavity of a patient.

A dialysis machine with machine-internal fluidics for dialysis fluid and a housing that at least partially encapsulates the fluidics, wherein the fluidics comprise an input line for fresh dialysis fluid to a dialyzer and an output line for used dialysis fluid from the dialyzer, each line equipped at their end sides with a connection port for a releasably coupling with the dialyzer, wherein the port of the input line and the port of the output line are each formed as a coupling integrated into the housing.

Technologies (e.g., devices, systems and methods) for sanitizing positive airway pressure (PAP) systems are described. In some embodiments, the technologies include a PAP delivery system comprising a hose and a PAP mask, a positive pressure supply system configured to generate a flow of pressurized air which is delivered to a user through the hose to the PAP mask of the PAP delivery system, a sanitizing system configured to sanitize one or more components of the self-sanitizing PAP system, and a PAP base unit housing, wherein one or more components of the positive pressure supply system and the sanitizing system are disposed at least partially within the PAP base unit housing.

An incentive spirometer medical device having a mouth piece protected by an enclosure when not in use and being able to be operated by one hand to open to access the mouth piece.

The present technology relates to a device and method to provide distilled water in pre-filled, disposable containers for use with humidifiers in assisted breathing units, such as continuous positive airway pressure (CPAP) devices. The technology also relates to methods for delivery of medications and inhalational and/or aromatic therapies through heated hydration chambers in CPAP devices and/or through nebulizers to be used to hydrate air in conjunction with CPAP devices. The present technology further relates to convenient multi-packs of pre-filled, disposable water containers to be provided in conjunction with CPAP devices.

This disclosure relates to a device for disinfecting CPAP components and a method of using the same. An example device includes a chamber, an ultraviolet (UV) light configured to emit UV light within the chamber, and a control unit configured to activate the UV light for a period of time.

A device, system, and method for isolating a ventilator from one or more patients in which the delivery conditions of gas delivered to an isolation device from a ventilator may drive the delivery of breathing-gas delivered to one or more patients, the breathing-gas having the same or different delivery conditions. In one embodiment, an isolation device may have a housing and a movable partition. The movable partition may be joined to the housing, The movable partition may have a patient side on a first side of the partition and an actuating side on a second side of the partition. The isolation device may include an inlet pressure regulator on the actuating side and/or an exhaust pressure regulator on the patient side. These regulators may alter the delivery conditions (including, but not limited to, pressure and volume) of breathing-gas delivered to a patient.

A breathing treatment apparatus delivers breathing gas to a user. The apparatus May be configured to comprise one or more sensors for sensing microbial growth within the apparatus.

Systems, methods, and devices related to removing fluids from a patient are provided. In one instance, fluid is removed from the patient and delivered to a canister using reduced pressure. Reduced pressure is supplied to the canister via a reduced-pressure delivery conduit that includes a moisture processing device and a hydrophobic filter. The moisture processing device condenses moisture from the air to prevent condensation from occluding the hydrophobic filter. The moisture processing devices includes an expanded volume and one or more liquid-impermeable, vapor-permeable membranes. The liquid-impermeable, vapor-permeable membrane allows vapor to egress the moisture processing device. Other systems, methods, and devices are presented.